0       0

Timely Topics in Transplantation Webcast Series


WEB161115 - Significance, Identification and Treatment of Post-thoracic Transplant Circulating Antibodies


Nov 15, 2016 2:00pm ‐ Nov 15, 2016 3:00pm


Credits: None available.

Standard: $25.00

Description

Moderator: Monica Colvin, MD, MS

The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation. What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?

After participating in this webinar, the learner will be able to:

  1. Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
  2. Order appropriate tests to detect relevant donor specific antibodies.

Speaker(s):

Credits

  • 0.00 - CE

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content